Intraoperative vasoplegia
Authors:
- 1 February 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Anaesthesiology
- Vol. 31 (1) , 43-49
Abstract
To evaluate the efficacy, dosing, and safety of methylene blue (MTB) in perioperative vasoplegic syndrome (VS). Vasoplegic syndrome is a state of persistent hypotension with elevated cardiac output, low filling pressures, and low systemic vascular resistance (SVR). It occurs in up to 25% of patients undergoing cardiac surgery with cardiopulmonary bypass, can last up to 72 h, and is associated with a high mortality rate. MTB has been found to increase SVR and decrease vasopressor requirements in vasoplegic syndrome by inhibiting nitric oxide synthase, thus limiting the generation of nitric oxide, while inhibiting activation of soluble guanylyl cyclase and preventing vasodilation. MTB has been used in postgraft reperfusion during liver transplantation and anaphylaxis in a limited number of cases. Additionally, this medication has been used in septic shock with promising results, but similar to the cardiac surgical population, the effects of MTB administration on clinical outcomes has yet to be elucidated. MTB should be considered during vasoplegic syndrome in cardiac surgery with cardiopulmonary bypass and usage may be more effective in an early critical window, prior to end-organ hypoperfusion. Other perioperative scenarios of MTB use show promise, but additional studies are required to develop formative conclusions.Keywords
This publication has 43 references indexed in Scilit:
- Vasoplegic Syndrome During Liver TransplantationAnesthesia & Analgesia, 2009
- Use of Methylene Blue for Catecholamine-Refractory Vasoplegia from Protamine and AprotininThe Annals of Thoracic Surgery, 2009
- The Hemodynamic Effects of Methylene Blue When Administered at the Onset of Cardiopulmonary BypassAnesthesia & Analgesia, 2006
- Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypassAnaesthesia, 2005
- Preoperative Methylene Blue Administration in Patients at High Risk for Vasoplegic Syndrome During Cardiac SurgeryThe Annals of Thoracic Surgery, 2005
- Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgeryThe Annals of Thoracic Surgery, 2004
- Use of intravenous methylene blue for the treatment of refractory hypotension after cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgeryThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Continuous infusion of methylene blue for septic shock1996
- Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shockIntensive Care Medicine, 1995